Abstract
This chapter describes a method for the multiplex analysis of six biallelic single nucleotide polymorphisms (SNPs) associated with thrombophilia. The method may, however, be adapted for the simultaneous analysis of up to 100 markers (50 biallelic SNPs) in a single reaction. In the method described, the targets of interest are amplified by single-tube multiplex PCR using six primer sets followed by single-tube multiplex allele-specific primer extension using 12 universally tagged genotyping primers. Labeled extension products are sorted using the xTAG™ universal bead-based array and detected on the Luminex xMAPˆledR system. The 12 universal tag sequences used in the assay derive from a set of 100 universal tags which have been designed to be isothermal and have been empirically validated to show that mismatch hybridization events are minimal. The method is suitable for cost-effective high-throughput clinical genotyping applications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Rosendaal, F. R. (1999) Venous thrombosis: a multicausal disease. Lancet 353, 1167–1173.
Franco, R. F., Reitsma, P. H. (2001) Genetic risk factors of venous thrombosis. Hum Genet 109, 369–384.
Bertina, R. M., Koeleman, B. P., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., et al. (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369, 64–67.
Poort, S. R., Rosendaal, F. R., Reitsma, P. H., Bertina, R. M. (1996) A common genetic variation in the ′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88, 3698–3703.
Frosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10, 111–113.
van der Put, N. M. J., Gabreels, F., Stevens, E. M. B., Smeitink, J. A. M., Trijbels, F. J. M., Eskes, T. K. A. B., et al. (1998) A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 62, 1044–1051.
Mikkola, H., Syrjala, M., Rasi, V., Vahtera, E., Hamalainen, E., Peltonen, L., Palotie, A. (1994) Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. Blood 84, 517–525.
Girard, T. J., Eddy, R., Wesselschmidt, R. L., MacPhail, L. A., Likert, K. M., Byers, M. G., et al. (1991) Structure of the human lipoprotein-associated coagulation inhibitor gene. J Biol Chem 266, 5036–5041.
Franco, R. F., Morelli, V., Lourenco, D., Maffei, F. H., Tavella, M. H., Piccinato, C. E., et al. (1999) A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease. Br J Haematol 105, 556–559.
Franco, R. F., Reitsma, P. H., Lourenco, D., Maffei, F. H., Morelli, V., Tavella, M. H., et al. (1999) Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis. Thromb Haemost 81, 676–679.
van Hylckama Vlieg, A., Komanasin, N., Ariens, R. A. S., Poort, S. R., Grant, P. J., Bertina, R. M., Rosendaal, F. R. (2002) Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep vein thrombosis. Br J Haematol 119, 169–175.
Kleesiek, K., Schmidt, M., Gotting, C., Brinkmann, T., Prohaska, W. (1998) A first mutation in the human tissue factor pathway inhibitor gene encoding [P151L]TFPI. Blood 92, 3976–3977.
Kleesiek, K., Schmidt, M., Gotting, C., Schwenz, B., Lange, S., Muller-Berghaus, G., et al. (1999) The 536C→T transition in the human tissue factor pathway inhibitor (TFPI) gene is statistically associated with a higher risk for venous thrombosis. Thromb Haemost 82, 1–5.
Evans, G. D., Langdown, J., Brown, K., Baglin, T. P. (2000) The C536T transition in the tissue factor pathway inhibitor gene is not a common cause of venous thromboembolic disease in the UK population. Thromb Haemost 83, 511.
Mullis, K. B., Faloona, F. A. (1987) Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 155, 335–350.
Markoulatos, P., Siafakas, N., Moncany, M. (2002) Multiplex polymerase chain reaction: a practical approach. J Clin Lab Anal 16, 47–51.
Ugozzoli, L., Wahlqvist, J. M., Ehsani, A., Kaplan, B. E., Wallace, R. B. (1992) Detection of specific alleles by using allele-specific primer extension followed by capture on solid support. Genet. Anal Tech Appl 9, 107–112.
Ye, F., Li, M., Taylor, J. D., Nguyen, Q., Colton, H. M., Casey, W. M., et al. (2001) Fluorescent microsphere-based readout technology for multiplexed human single nucleotide polymorphism analysis and bacterial identification. Hum Mutat 17, 305–316.
Dunbar, S. A. (2006) Applications of LuminexˆledR xMAP™ technology for rapid, high-throughput multiplexed nucleic acid detection. Clin Chim Acta 363, 71–82.
Bortolin, S., Black, M., Modi, H., Boszko, I., Kobler, D., Fieldhouse, D., et al. (2004) Analytical validation of the Tag-It high-throughput microsphere-based universal array genotyping platform: application to the multiplex detection of a panel of thrombophilia-associated single-nucleotide polymorphisms. Clin Chem 50, 2028–2036.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Bortolin, S. (2008). Multiplex Genotyping for Thrombophilia-Associated SNPs by Universal Bead Arrays. In: Bugert, P. (eds) DNA and RNA Profiling in Human Blood. METHODS IN MOLECULAR BIOLOGY™, vol 496. Humana Press. https://doi.org/10.1007/978-1-59745-553-4_6
Download citation
DOI: https://doi.org/10.1007/978-1-59745-553-4_6
Publisher Name: Humana Press
Print ISBN: 978-1-934115-93-0
Online ISBN: 978-1-59745-553-4
eBook Packages: Springer Protocols